| scholarly article | Q13442814 |
| P2093 | author name string | Mark Wallace | |
| Gery Schulteis | |||
| Vicky Y. Lam | |||
| P2860 | cites work | Neurogenic hyperalgesia: psychophysical studies of underlying mechanisms | Q45020805 |
| The effect of intravenous ketorolac on capsaicin-induced deep tissue hyperalgesia | Q46131545 | ||
| A multicenter, double-blind, randomized, placebo-controlled crossover evaluation of a short course of 4030W92 in patients with chronic neuropathic pain | Q46470852 | ||
| Skin biopsy and quantitative sensory testing do not predict response to lidocaine patch in painful neuropathies | Q48768731 | ||
| Lidocaine patch 5% and its positive impact on pain qualities in osteoarthritis: results of a pilot 2-week, open-label study using the Neuropathic Pain Scale | Q48823796 | ||
| Inhibition of neuropathic pain by decreased expression of the tetrodotoxin-resistant sodium channel, NaV1.8. | Q51338352 | ||
| Mechanisms for differential block among single myelinated and non-myelinated axons by procaine | Q52725855 | ||
| Pain, hyperalgesia and activity in nociceptive C units in humans after intradermal injection of capsaicin | Q68136348 | ||
| Sensations evoked by intraneural microstimulation of C nociceptor fibres in human skin nerves | Q69476652 | ||
| The capsaicin receptor: a heat-activated ion channel in the pain pathway | Q24322558 | ||
| An SCN9A channelopathy causes congenital inability to experience pain | Q28278844 | ||
| Effect of EMLA pre-treatment on capsaicin-induced burning and hyperalgesia | Q28374767 | ||
| A tetrodotoxin-resistant voltage-gated sodium channel expressed by sensory neurons | Q28570486 | ||
| Vanilloid (Capsaicin) receptors and mechanisms | Q29617371 | ||
| Postherpetic neuralgia: topical lidocaine is effective in nociceptor-deprived skin | Q33213049 | ||
| Topical capsaicin in humans: parallel loss of epidermal nerve fibers and pain sensation | Q33863807 | ||
| The tetrodotoxin-resistant sodium channel SNS has a specialized function in pain pathways | Q33871067 | ||
| Type III sodium channel mRNA is expressed in embryonic but not adult spinal sensory neurons, and is reexpressed following axotomy | Q37019966 | ||
| Staircase bioassay: the up-and-down method | Q37762560 | ||
| Pharmacokinetics and safety of continuously applied lidocaine patches 5%. | Q38486616 | ||
| Efficacy of lidocaine patch 5% in the treatment of focal peripheral neuropathic pain syndromes: a randomized, double-blind, placebo-controlled study | Q39388670 | ||
| Lidocaine patch 5%. | Q39431826 | ||
| Topical lidocaine patch relieves postherpetic neuralgia more effectively than a vehicle topical patch: results of an enriched enrollment study | Q39438845 | ||
| Lidocaine patch: double-blind controlled study of a new treatment method for post-herpetic neuralgia | Q39466132 | ||
| Intraneural microstimulation in man. Its relation to specificity of tactile sensations | Q39689465 | ||
| The effects of local and intravenous anesthetics on recombinant rat VR1 vanilloid receptors | Q40645974 | ||
| Concentration-effect relations for intravenous lidocaine infusions in human volunteers: effects on acute sensory thresholds and capsaicin-evoked hyperpathia | Q42549025 | ||
| Concentration-effect relationships for intravenous alfentanil and ketamine infusions in human volunteers: effects on acute thresholds and capsaicin-evoked hyperpathia | Q43480929 | ||
| A human oral capsaicin pain model to assess topical anesthetic-analgesic drugs. | Q43823509 | ||
| Lack of effect of two oral sodium channel antagonists, lamotrigine and 4030W92, on intradermal capsaicin-induced hyperalgesia model | Q43922751 | ||
| A randomized study of the effect of oral lamotrigine and hydromorphone on pain and hyperalgesia following heat/capsaicin sensitization | Q44378400 | ||
| Effectiveness, tolerability, and impact on quality of life of the 5% lidocaine patch in diabetic polyneuropathy | Q44946961 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | lidocaine | Q216935 |
| transdermal patch | Q1145270 | ||
| P304 | page(s) | 323-330 | |
| P577 | publication date | 2011-03-01 | |
| P1433 | published in | The Journal of Pain | Q15733728 |
| P1476 | title | Effects of lidocaine patch on intradermal capsaicin-induced pain: a double-blind, controlled trial | |
| Effects of Lidocaine Patch on Intradermal Capsaicin-Induced Pain: A Double-Blind, Controlled Trial | |||
| P478 | volume | 12 |
| Q41933385 | 5% lidocaine medicated plaster double effect in a case of orofacial localized neuropathic pain |
| Q38839940 | A literature review on the pharmacological sensitivity of human evoked hyperalgesia pain models |
| Q46871618 | A randomized, double-blind, crossover study to evaluate the depth response relationship of intradermal capsaicin-induced pain and hyperalgesia in healthy adult volunteers |
| Q48246227 | Antihyperalgesic efficacy of 5% lidocaine medicated plaster in capsaicin and sunburn pain models--two randomized, double-blinded, placebo-controlled crossover trials in healthy volunteers. |
| Q36389022 | Brain networks predicting placebo analgesia in a clinical trial for chronic back pain |
| Q38198093 | Capsaicin 8% patch for peripheral neuropathic pain: review of treatment best practice from 'real-world' clinical experience |
| Q38049522 | Capsaicin for neuropathic pain: linking traditional medicine and molecular biology |
| Q36329277 | Lidocaine patch (5%) is no more potent than placebo in treating chronic back pain when tested in a randomised double blind placebo controlled brain imaging study. |
| Q42736007 | Localized neuropathic pain: an expert consensus on local treatments |
| Q46051648 | Reliability study of thermal quantitative sensory testing in healthy Chinese |
| Q34376548 | Topical analgesics for neuropathic pain: preclinical exploration, clinical validation, future development |
| Q34805660 | Treatment of neuropathic pain with the capsaicin 8% patch: is pretreatment with lidocaine necessary? |
Search more.